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munity,especially for thedonor’s family, andmust includepos-
sible responses to incidental findings. This means there is a
responsibility to consider potential downstream effects (eg,
heritable diseases) on the families of those who donate their
bodies. Issues suchas theappropriateacquisition, storage,use,
and destruction of the generated information also need to be
considered tocontribute toa robust andethicalpractice frame-
work. Deciding how to proceed should include discussion
within the broader academic community, as themechanisms
for how to deal with these issues in the living remain difficult
and there is no clear consensus.4
Although in the United States, as the authors stated, there
are no legal or regulatory hurdles when using cadaver tissue
(because human research regulations only cover living indi-
viduals), this isnot thecaseworldwide.5 Irrespectiveof the legal
aspects,however, theethicalaspectsofusinghumantissuesthat
were altruisticallydonated formedical educationneed tobeat
the forefront when considering the use of this technology.
The motivation for medical education to include practi-
cal experience of genetic testing has merit. We urge caution
with respect to theuseof this new technology inmedical edu-
cation wherein willed bodies are involved, and suggest wide
consultation is required to develop appropriate ethical
practices for this purpose.
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In ReplyWecould only briefly highlight key ethical issues per-
taining to the use of exome sequence data obtained from in-
dividualswhohavedonated their bodies for teachinganatomy
tomedical students in our Viewpoint, whichDr Cornwall and
colleagues have described in more detail.
Althoughnot required,ourprogramis fully compliantwith
the International Federation of Associations of Anatomists'
guidelinesand incorporatedguidance fromour institutional re-
view board regarding both the use of DNA from cadavers and
the reportingof aneducational initiative. Part ofour intentwas
to generate interest and discussion in this area, for which, as
Cornwall and colleagues point out, only a paucity of ethical
guidelines and thought exists. The consent for total body do-
nation to theHumanityGiftsRegistryof theCommonwealthof
Pennsylvania1 allows for use for anatomical study, research, or
both. However, it also states that “no reports will be provided
to the family.” We are thus precluded from returning results
basedonincidentalorsecondaryfindings. Indeed,ageneticdis-
ease in the donorwith implications for relativesmay be found
through thediscoveryof anatomical andpathological findings
duringdissectionwithout anygenetic analysis.Ourprogram is
also not conducted under clinical grade standards and regula-
tory requirements, which would require substantial addi-
tional resources to be a diagnostic program. Even with DNA
sequencing performed for clinical care, a consensus does not
yet exist on which incidental or secondary findings should be
returned to patients, practical guidance is limited, and na-
tional and international standards are lacking.2 Despite these
deficiencies, such testing is growing substantially.
WeagreewithCornwall and colleagues that themerit and
valueof our approachwarrantmorework to identifybest ethi-
cal practices. However, we believemore data are required be-
fore a consensus based on the “wide consultation” suggested
by Cornwall and colleagues can be reached. Multiple stake-
holders accruing real-world experience in a diversity of set-
tingsandusingvariousapproachesareneeded,aswell as fund-
ing to support research into the ethical, legal, and social
implications of this type of educational initiative.
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Public Health andHumanRights
To the EditorDr Galea andMr Annas called for greater priority
to be given to public health vs more individualized methods
to improvepopulationhealth.1Weagreewith theauthors’ rec-
ommendation for a multisectorial approach to public health
that engages academia, industry, and the not-for-profit
sector. We wish to highlight, however, the authors’ proposal
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that theUniversalDeclarationofHumanRights (UDHR) should
be formally adopted as the code of public health ethics.
Althoughwe endorse the public health role of human rights,2
an exclusively rights-based approach generates 2 serious
challenges that the authors did not address.
First, it iswidelyassumed thathumanrights, includingca-
nonical instruments such as the UDHR, apply exclusively to
states. This assumption seems to be shared by the authors
when they wrote that human rights are appropriate to public
health because “muchof public health is still directed by gov-
ernments.” But their focus on “governmental obligations” is
in tension with their recommendation for a multisectorial
strategy. Mobilizing human rights for public health needs to
reflect the fact that human rights obligations extend beyond
the state, encompassingmany kinds of nongovernmental ac-
tors. A recent example of this is the United Nation’s Guiding
Principles onBusiness andHumanRights,3whichdirectly im-
pose on corporations a responsibility to respect all human
rights, including the right to health.
Second, the authors did not address the potential tension
that exists between human rights and public health. Human
rights are individualistic in focus, beingconcernedwithclaims
that individuals can make to the provision of certain ben-
efits. By contrast, public health is geared toward aggregate
health goods delivered to populations as a whole. Therefore
there isaseriousquestiontowhatextentacodeofhumanrights
alone canbe a comprehensive ethical basis for public health.4
For example, a common good such as widespread participa-
tion in physical activity is vital to population health, but not
something that can be completely guaranteed by upholding
human rights. Examples such as this suggest that consider-
ations of the common good in addition to human rights will
be needed when seeking an ethical basis for public health.5
Human rights are important to public health, and their
importance extends beyond governments, but the ethics of
public health need more than human rights.
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In Reply Our Viewpoint made a specific proposal: “Formally
adopt the Universal Declaration of HumanRights as the Code
of Public Health Ethics.” Drs Tasioulas and Vayena seem to
want todisagree, butultimatelyprovide additional support by
asking us to comment on “2 serious challenges.”
First, it is true as a matter of law that human rights obli-
gations are primarily state obligations. Nonetheless, non-
state actors, including corporations, nongovernmental orga-
nizations, and even intergovernmental organizations like the
World Health Organization, can adopt human rights in gen-
eral or the UDHR in particular as their ethical code.1,2 These
actors do not have the same legal obligations as governments
to respect, protect, and fulfill human rights, but certainly can
voluntarily agree touse themas their ethical guide. TheWorld
Health Organization, for example, states in its 2005 Interna-
tionalHealthRegulations: “The implementationof these [r]egu-
lations shall bewith full respect for thedignity, human rights,
and fundamental freedoms of persons.”
Second, the claim that human rights, because they are in-
dividualistic, are in tensionwithpublic health iswidely stated
in theory but not documented in practice. Human rights and
publichealthshare thesamegoal,which ishumanflourishing.3
It is true that public healthworks on the population level, but
many human rights do as well. There are different categories
of human rights in the UDHR: articles 3 through 11 are about
life, liberty, and personal security (and are themost individu-
alistic); articles 12 through21 address rights in civil society and
the polity; and articles 22 through 27 concern economic, so-
cial, and cultural rights.4 The latter includebroadpopulation-
based rights, including the right to social security, work, rest,
a standard of living adequate for health and well-being, edu-
cation, and participation in cultural life and scientific ad-
vances. Childress and colleagues5 is cited for the proposition
that human rightsmay not provide a “comprehensive ethical
basis for public health,” but the authors of that article never
explicitly say that, instead suggesting only that “sometimes”
itmaybe that “a societycannot simultaneously realize its com-
mitments to public health and to [human rights]….” This
argument is not about human rights as a guide but about its
ability to provide a solution to every complex dilemma.
Human rights are based on the human dignity of all with-
out discrimination. They are about the good of everyone and
can (and should) be used by public health “in ways that
directlypromotepopulationhealthandadvancesocial justice.”6
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CORRECTION
Misspelled Author Name: In the Infographic “Eligibility and Coverage Trends in
Employer-Sponsored Insurance,” published in the May 3, 2016, issue of JAMA,1
an author’s surnamewas spelled incorrectly. This article was corrected online.
1. LongM, RaeM, Claxton G, Jankiewicz A, Rousseau D; Kaiser Family
Foundation. Eligibility and coverage trends in employer-sponsored insurance.
JAMA. 2016;315(17):1824.
AdditionalAuthorAffiliation: In theOriginal Investigation “Antiplatelet Therapy
Duration Following Bare Metal or Drug-Eluting Coronary Stents: The Dual
Antiplatelet Therapy Randomized Clinical Trial,” published in the March 17, 2015,
issue of JAMA,1 one of the authors was missing an institution from his affiliation.
This article was corrected online. This article was also corrected in April 2015 for
errors in describing the prespecified analyses.2
1. Kereiakes DJ, Yeh RW,Massaro JM, et al. Antiplatelet therapy duration
following bare metal or drug-eluting coronary stents: the Dual Antiplatelet
Therapy randomized clinical trial. JAMA. 2015;313(11):1113-1121.
2. Incorrect representation of analyses [correction]. JAMA. 2015;313(21):2185.
Guidelines for Letters
Letters discussing a recent JAMA article should be submitted within 4
weeksof thearticle's publication inprint. Letters receivedafter4weeks
will rarely be considered. Letters should not exceed 400words of text
and 5 references andmay have nomore than 3 authors. Letters report-
ing original research should not exceed 600words of text and 6 refer-
ences andmay have nomore than 7 authors. Theymay include up to 2
tables or figures but online supplementary material is not allowed. All
letters should include a word count. Letters must not duplicate other
material published or submitted for publication. Letters not meeting
these specifications are generally not considered. Letters being consid-
ered for publication ordinarily will be sent to the authors of the JAMA
article, who will be given the opportunity to reply. Letters will be pub-
lishedat thediscretionof theeditorsandaresubject toabridgementand
editing. Further instructions can be found at http://jama.com/public
/InstructionsForAuthors.aspx. A signed statement for authorship crite-
ria and responsibility, financial disclosure, copyright transfer, and
acknowledgment and the ICMJE Form for Disclosure of Potential
Conflicts of Interest are required before publication. Letters should be
submitted via the JAMA online submission and review system at
http://manuscripts.jama.com. For technical assistance, please contact
jama-letters@jamanetwork.org.
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